Drugs
Researchers in Japan, Switzerland, and Germany have published groundbreaking studies on cancer vaccines, offering new hope for cancer patients. The studies focus on developing potent immunogenic general cancer vaccines that target survivin, an inhibitor of apoptosis proteins. One study found that a HLA-A24-restricted antigenic peptide, survivin-2B80-88, recognized by CD8+ CTL,
Drugs
Researchers at the University of Minnesota investigated the impact of arsenic trioxide on primary cultures of endothelial cells and tumor tissue under varying pH and pO[subscript]2 environments. The study aimed to determine whether combined arsenic trioxide and radiation therapy could synergistically increase the effectiveness of cancer treatment. The
Drugs
Scientists at Cell Genesys, Inc., have developed a proprietary gene expression technology that enables the production of full-length monoclonal antibodies at commercially relevant levels from a single production cell line. This innovative technology, which uses adeno-associated viral (AAV) or other viral-based genetic engineering, can significantly shorten the time required to
Cancer treatment
Researchers at the University of Dundee have found that metformin, a commonly used drug for type 2 diabetes treatment, may have a reduced cancer risk of over 25%. Preliminary findings published in the British Medical Journal suggest that metformin users are less likely to develop cancer compared to diabetic patients
Cancer treatment
At the 2005 American Society of Clinical Oncology Meeting in Orlando, Florida, Antisoma presented positive phase I data for its vascular disrupting agent AS1404, paving the way for its progression into phase II trials. The data from the 'DART' study showed a clear therapeutic window, where a well-tolerated
Cancer treatment
Adventrx Pharmaceuticals, Inc., has announced that two abstracts featuring CoFactor toxicity and pharmacodynamics data were presented at the American Association for Cancer Research (AACR) Annual Meeting. The data were collected from the company's ongoing CoFactor phase II clinical trial in metastatic colorectal cancer and a recent preclinical study.
Cancer treatment
Researchers in the United States and The Netherlands have reported significant advancements in cancer vaccine development, with studies focusing on p53-based immunization and redirecting cytolytic capacity of cytotoxic T lymphocytes toward tumor vascular endothelial cells. These breakthroughs offer new insights into the potential of cancer vaccines in preventing and treating
Drugs
A new study published in Cancer Research has shown that a genetically altered herpes simplex virus can significantly increase the survival of mice with an incurable human brain tumor, even in some animals with advanced disease. The virus infects and reproduces only in malignant glioma cells, killing them while leaving
Drugs
Scientists in the United States and People's Republic of China have made significant advancements in cancer therapy by exploring novel angiogenesis inhibitors, compounds that can halt the growth of new blood vessels that feed tumors, thereby preventing cancer progression and metastasis. Recent studies have shed light on the
Drugs
Scientists are exploring the use of DNA tumor viruses to understand cancer cell programming and develop therapeutic strategies to target tumor cells. Recent research suggests that these viruses can provide valuable insights into the molecular lesions that drive tumorigenesis and maintenance. Additionally, DNA tumor viruses have the potential to trigger
Drugs
Researchers from the People's Republic of China, Japan, and South Korea have made significant advancements in oncology, including the development of orally administered bacteria that transport anticancer genes in mice, the use of an anti-endostatin antibody to study its effectiveness in fighting liver cancer, and the aerosol delivery
Cytological research
Research conducted by scientists at the Mt Sinai School of Medicine has shed light on the complex relationship between COX-2, a protein that promotes tumor growth, and p53, a tumor suppressor protein. The study, published in the Journal of Biological Chemistry, found that COX-2 inhibition can restore p53 activity in
